Kuros Biosciences AG (FRA:YTSN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,121	859	138	54	61	61
Market Cap Growth	29.11%	523.03%	153.55%	-10.72%	-0.52%	20.93%
Enterprise Value	1,103	846	123	35	37	50
Last Close Price	27.92	-	-	-	1.41	1.41
PS Ratio	10.13	10.66	3.82	2.99	4.57	16.40
PB Ratio	13.66	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	30.06	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	-	393.96	-	-	-	-
P/OCF Ratio	1277.07	256.57	-	-	-	-
EV/Sales Ratio	9.95	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	158.58	385.86	-	-	-	-
EV/EBIT Ratio	266.87	7414.24	-	-	-	-
EV/FCF Ratio	-1528.96	387.93	-	-	-	-
Debt / Equity Ratio	0.02	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.28	0.66	-	-	-	-
Debt / FCF Ratio	-	0.88	-	-	-	-
Asset Turnover	1.10	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.14	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.68	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.25	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-8.62%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	2.57%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	3.43%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	4.60%	0.20%	-8.20%	-14.00%	-11.00%	-13.00%
Earnings Yield	-0.58%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	-0.06%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-36.07%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.